Is There any Alternative Receptor for SARS-CoV-2?

Is There any Alternative Receptor for SARS-CoV-2?

Angiotensin-converting enzyme II (ACE2) in association with type II transmembrane serine protease (TMPRSS2) is considered the main receptor of SARS-CoV-2. However, considering the clinical complications of COVID-19 in different organs, there is no strong association between the abundance of ACE2/...

Full description

Bibliographic Details
Main Authors:	Mahtab Shahriari Felordi, Arash Memarnejadian, Mustapha Najimi, Massoud Vosough
Format:	Article
Language:	English
Published:	Royan Institute (ACECR), Tehran 2021-07-01
Series:	Cell Journal
Subjects:	angiotensin-converting enzyme ii covid-19 endoplasmic reticulum stress hspa5 sars-cov-2
Online Access:	https://celljournal.org/journal/article/fulltext/grp78-an-alternative-receptor-for-sars-cov-2.pdf

Similar Items

Does Angiotensin II Peak in Response to SARS-CoV-2?
by: Léder Leal Xavier, et al.
Published: (2021-01-01)

Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells
by: Yibing Chen, et al.
Published: (2019-09-01)

Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences
by: Agnieszka Dettlaff-Pokora, et al.
Published: (2021-04-01)

In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2
by: Yamil Liscano, et al.
Published: (2020-11-01)

Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?
by: Giovanni Li Volti, et al.
Published: (2020-05-01)

Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses
by: Morvarid Siri, et al.
Published: (2021-06-01)

Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
by: Seyed-Mohammad Ghahestani, et al.
Published: (2020-05-01)

Interaction of SARS-CoV-2 spike protein with angiotensin converting enzyme inhibitors and selected compounds from the chemical entities of biological interest
by: Suleiman Aminu, et al.
Published: (2021-08-01)

Renal Injury by SARS-CoV-2 Infection: A Systematic Review
by: Mo Wang, et al.
Published: (2020-11-01)

The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection
by: Jessica Maiuolo, et al.
Published: (2020-12-01)

SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis
by: Jincheng Xu, et al.
Published: (2020-07-01)

Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
by: Jingwei Bian, et al.
Published: (2021-01-01)

Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress
by: Qingyu Zhang, et al.
Published: (2019-03-01)

Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells
by: Gabriel Augusto Pires de Souza, et al.
Published: (2021-06-01)

SARS-CoV-2 virus: origin, structure and replication cycle
by: Katarzyna Kuczyńska, et al.
Published: (2021-04-01)

SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene
by: Jibran Sualeh Muhammad, et al.
Published: (2021-02-01)

Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor
by: Zahra Eslamifar, et al.
Published: (2020-12-01)

The Use of ACE inhibitor/ARB in SARS-CoV-2 Patients: A Comprehensive Narrative Review
by: Timotius Ivan Hariyanto, et al.
Published: (2020-11-01)

Activation of Ang-(1-7)/Mas Receptor Is a Possible Strategy to Treat Coronavirus (SARS-CoV-2) Infection
by: Giselle Santos Magalhaes, et al.
Published: (2020-06-01)

SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses
by: Abdo A. Elfiky
Published: (2020-12-01)

Long-Term Angiotensin II Infusion Induces Oxidative and Endoplasmic Reticulum Stress and Modulates Na+ Transporters Through the Nephron
by: Bruna Bezerra Lins, et al.
Published: (2021-04-01)

Vigilance on New-Onset Atherosclerosis Following SARS-CoV-2 Infection
by: Ya Liu, et al.
Published: (2021-01-01)

Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection
by: S. Seltzer
Published: (2020-12-01)

Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
by: Meng-Yuan Li, et al.
Published: (2020-04-01)

ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues
by: Sally Badawi, et al.
Published: (2021-01-01)

In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets
by: Chidi Edbert Duru, et al.
Published: (2021-03-01)

Current Status of Endoplasmic Reticulum Stress in Type II Diabetes
by: Sagir Mustapha, et al.
Published: (2021-07-01)

Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets
by: Jitendra Kumar Chaudhary, et al.
Published: (2021-09-01)

Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19
by: Rohitash Yadav, et al.
Published: (2021-04-01)

Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules
by: Kenana Al Adem, et al.
Published: (2020-12-01)

SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity
by: Somasundaram Raghavan, et al.
Published: (2021-06-01)

Acute Ischemic Stroke in SARS-CoV, MERS-CoV, SARS-CoV-2: Neurorehabilitation Implications of Inflammation Induced Immunological Responses Affecting Vascular Systems
by: Leila Karimi, et al.
Published: (2020-12-01)

Localization of Cell Receptor-Related Genes of SARS-CoV-2 in the Kidney through Single-Cell Transcriptome Analysis
by: Qi-Lin Chen, et al.
Published: (2020-05-01)

Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells
by: Brini, M., et al.
Published: (2022)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
by: Federica Saponaro, et al.
Published: (2020-09-01)

Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach
by: Santosh Kumar Behera, et al.
Published: (2021-01-01)

ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets
by: Thomas A. Strong, et al.
Published: (2021-12-01)

Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2
by: Lucia Longhitano, et al.
Published: (2020-05-01)

DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2
by: Fabrizio Cleri, et al.
Published: (2021-08-01)

SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
by: Simona Iacob, et al.
Published: (2020-08-01)